Clinical Trial

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

Study acronym: MAGNETIC-AF
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-02.
Trial Details
NCT Number NCT07632157
Lead Sponsor Wake Forest University Health Sciences
Conditions Atrial Flutter With Rapid Ventricular Response
Enrollment 196 participants
Start Date 2026-10
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-29